Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Opris

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
SAR and QSAR in Environmental Research|November 8, 2001
Peptide property modeling by Cluj indicesD Opris, M V Diudea
Lupus|June 4, 2016
Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?A Dima, D Opris, C Jurcut, et al.
Journal of Medicine and Life|August 2, 2013
The serotonin and the bone assessmentM Carsote, V Radoi, A Geleriu, et al.
Journal of Medicine and Life|April 15, 2015
Serotonin and the bone assessmentM Carsote, V Radoi, A Geleriu, et al.
Journal of Medicine and Life|September 15, 2015
Socio-economical factors that influence the perception of quality of life in patients with osteoporosisM Abobului, F Berghea, V Vlad, et al.
Journal of Medicine and Life|September 12, 2015
Evaluation of adherence to anti-osteoporosis treatment from the socio-economic contextM Abobului, F Berghea, V Vlad, et al.
Seminars in Arthritis and Rheumatism|November 6, 2022
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trialL Hartman, M El Alili, M Cutolo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
SAR and QSAR in Environmental Research|November 8, 2001
Peptide property modeling by Cluj indicesD Opris, M V Diudea
Lupus|June 4, 2016
Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?A Dima, D Opris, C Jurcut, et al.
Journal of Medicine and Life|August 2, 2013
The serotonin and the bone assessmentM Carsote, V Radoi, A Geleriu, et al.
Journal of Medicine and Life|April 15, 2015
Serotonin and the bone assessmentM Carsote, V Radoi, A Geleriu, et al.
Journal of Medicine and Life|September 15, 2015
Socio-economical factors that influence the perception of quality of life in patients with osteoporosisM Abobului, F Berghea, V Vlad, et al.
Journal of Medicine and Life|September 12, 2015
Evaluation of adherence to anti-osteoporosis treatment from the socio-economic contextM Abobului, F Berghea, V Vlad, et al.
Seminars in Arthritis and Rheumatism|November 6, 2022
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trialL Hartman, M El Alili, M Cutolo, et al.
Pageof 1